{"disease":{"id":"rotavirus","name":"Rotavirus","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"vaccine-administration","indication_name":"Rotavirus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vaccine Support Cp","generic_name":"Vaccine administration","company_name":"Women and Infants Hospital of Rhode Island","drug_phase":"marketed","molecular_target":"unknown","drug_class":"vaccine","quality_score":45,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00875641","title":"Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":390659,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00140673","title":"A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":63227,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT04010448","title":"A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":8200,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT05958771","title":"The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":5800,"lead_sponsor_name":"University of Chile","has_results":false},{"nct_id":"NCT01733862","title":"Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis","phase":"","overall_status":"COMPLETED","enrollment_count":5394,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03870061","title":"Evaluation of an Infant Immunization Encouragement Program in Nigeria","phase":"NA","overall_status":"COMPLETED","enrollment_count":5187,"lead_sponsor_name":"GiveWell","has_results":false},{"nct_id":"NCT03550937","title":"Hospital-based Surveillance of Rotavirus Gastroenteritis in Young Taiwanese Children","phase":"","overall_status":"COMPLETED","enrollment_count":5040,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT02062385","title":"Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4040,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01171963","title":"Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3340,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00750893","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants","phase":"","overall_status":"COMPLETED","enrollment_count":3111,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00385320","title":"Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2640,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04819412","title":"To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1975,"lead_sponsor_name":"Bharat Biotech International Limited","has_results":false},{"nct_id":"NCT00420316","title":"Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1613,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02914184","title":"Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1612,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06882070","title":"ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage","phase":"","overall_status":"COMPLETED","enrollment_count":1600,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT03474055","title":"Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Serum Institute of India Pvt. Ltd.","has_results":false},{"nct_id":"NCT00353366","title":"To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":1439,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04185545","title":"Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT03954743","title":"Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1351,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03207750","title":"This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1280,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00363545","title":"To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1274,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01600092","title":"A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1020,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00420745","title":"To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1009,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00653198","title":"Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama","phase":"","overall_status":"COMPLETED","enrollment_count":885,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04344054","title":"Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":850,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT03703336","title":"Phase III Study of Liquid Formulation of ROTAVIN","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":825,"lead_sponsor_name":"Center for Research and Production of Vaccines and Biologicals, Vietnam","has_results":true},{"nct_id":"NCT03587389","title":"Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":818,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT00480324","title":"Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":765,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04658914","title":"Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Centre for Infectious Disease Research in Zambia","has_results":false},{"nct_id":"NCT03483116","title":"A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":711,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":true},{"nct_id":"NCT00969228","title":"Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01177826","title":"Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children","phase":"","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT06080906","title":"Phase II Clinical Trial of the Inactivated Rotavirus Vaccine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Institute of Medical Biology, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT00779779","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants","phase":"","overall_status":"COMPLETED","enrollment_count":522,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04429295","title":"Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":460,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT02141204","title":"Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":451,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03602053","title":"Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Centre for Infectious Disease Research in Zambia","has_results":true},{"nct_id":"NCT04481191","title":"Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06967272","title":"PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Sinovac Life Sciences Co., Ltd.","has_results":false},{"nct_id":"NCT00432380","title":"A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":375,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00289172","title":"Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04596696","title":"Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Bharat Biotech International Limited","has_results":false},{"nct_id":"NCT00938327","title":"Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants","phase":"","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02907216","title":"Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":292,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03313128","title":"SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance","phase":"","overall_status":"COMPLETED","enrollment_count":261,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT00443846","title":"RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00533507","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02992197","title":"The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"University of Vermont","has_results":true},{"nct_id":"NCT00396630","title":"A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}